Drug and Gene Delivery to Mucosal Surfaces

Justin Hanes

Justin Hanes

Lewis J. Ort Professor & Director, The Center for Nanomedicine

Johns Hopkins School of Medicine

Justin Hanes is the Lewis J. Ort Professor and Director of the Center for Nanomedicine at the Johns Hopkins University School of Medicine. He holds faculty appointments in Biomedical Engineering, Chemical & Biomolecular Engineering, Environmental Health Sciences, Neurosurgery, Oncology, and a primary appointment in Ophthalmology. He directs a research program at the interface of biomaterials, bioengineering, drug delivery and translational medicine at Johns Hopkins. He is a founder and member of the board of directors of Kala Pharmaceuticals, a company commercializing his laboratory¹s ³mucus penetrating particle² nanotechnology, and he is founder, CEO and Chair of the Board of Directors of GrayBug, a private company developing advanced drug delivery systems with a focus on the treatment of diseases that affect vision. He also serves on the scientific advisory board for Genentech in the Drug Delivery Division, and as Chair of the Gene and Drug Delivery study section for the NIH. Justin received a B.S. in Chemical Engineering from UCLA in 1991 and Ph.D. in Chemical Engineering from MIT in 1996. He did postdoctoral training in Oncology and Neurosurgery at the Johns Hopkins University School of Medicine in 1996-1998.

Sponsor & Exhibitor Opportunities

 Exhibit and Showcase
 Become a Sponsor

Please contact: Denise Lee


TechConnect Acceleration Partners:

BASF
BayerMaterialScience
Battelle
Bosch
bp
DOW
GE
Honda
Hyundai
Ingersoll Rand
intel
Lockheed Martin
MWV
Merck
novaris
Panasonic
Procter And Gamble
PPG
Roche
Sanofi
Shell_GameChanger
siemens
solvay
Toyota.gif

In Partnership with

NSTI


Sponsorship Opportunities: Contact Denise Lee

Free Subscription

E-mail:

pbh(); ?>